857138C

18:2 Lyso PA

Avanti Research^™ - A Croda Brand

• 동의어(들): 1-(9Z,12Z-octadecadienoyl)-2-hydroxy-sn-glycero-3-phosphate (sodium salt); PA(18:2(9Z,12Z)/0:0)
• 실험식(Hill 표기법): C₂₁H₃₈NaO₇P
• CAS Number: 65528-85-0
• Molecular Weight: 456.49
• MDL number: MFCD00672604
• UNSPSC 코드: 51191904
• NACRES: NA.25

속성

• 설명: 1-linoleoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt), chloroform
• 분석: >99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
• 양식: liquid
• 포장: pkg of 1 × 1 mL (857138C-10mg); pkg of 1 × 2.5 mL (857138C-25mg)
• 제조업체/상표: Avanti Research^™ - A Croda Brand
• 농도: 10 mg/mL (857138C-10mg); 10 mg/mL (857138C-25mg)
• 지질 유형: cardiolipins; phospholipids
• 배송 상태: dry ice
• 저장 온도: −20°C

설명

일반 설명

Lysophosphatidic acid (LPA) is a lysophospholipid comprising of glycerol 3-phosphate (G3P), fatty acids, and phosphates.

생화학적/생리학적 작용

18:2 Lysophosphatidic acid (LPA) is an active ingredient of gintonin, which is a bioactive ligand of ginseng. LPA is synthesized in plants by the activity of the enzyme glycerol 3-phosphate acyltransferase (GPAT). LPA is an intermediate in the synthesis of phosphatidic acid (PA) and other phospholipids. Abnormal LPA metabolism is found in children with autism.

포장

5 mL Clear Glass Sealed Ampule (857138C-10mg)

5 mL Clear Glass Sealed Ampule (857138C-25mg)

법적 정보

Avanti Research is a trademark of Avanti Polar Lipids, LLC

안전성 정보

• 픽토그램: GHS06,GHS08
• 신호어: Danger
• 유해 및 위험 성명서: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• 예방조치 성명서: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 표적 기관: Central nervous system, Liver,Kidney
• Storage Class Code: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• WGK: WGK 3
• Flash Point (°F): does not flash
• Flash Point (°C): does not flash